LSL Pharma Group Inc (LSL-DB.CA) Stock Cash Flow
TSX-V:LSL-DB - TSX Venture Exchange - - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -1.66M | -8.47M | -70.00K | -90.00K | |||
| Depreciation Amortization | 1.28M | 1.13M | N/A | N/A | |||
| Change In Working Capital | -4.14M | -4.74M | 70.00K | 20.00K | |||
| Interest Paid | 746.00K | 1.04M | N/A | N/A | |||
| Other non cash items | 1.45M | 5.01M | N/A | N/A | |||
| OPERATING CASH FLOW | -3.07M | -7.07M | 0.00 | -70.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -2.64M | -1.02M | N/A | N/A | |||
| INVESTING CASH FLOW | -4.66M | -1.02M | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 1.39M | 1.46M | N/A | N/A | |||
| Stock Issued/Repurchased | 8.23M | 9.46M | N/A | N/A | |||
| Other Financing Activity | -1.69M | -2.83M | 0.00 | 70.00K | |||
| FINANCING CASH FLOW | 7.92M | 8.10M | 0.00 | 70.00K | |||
| CHANGE IN CASH | 192.60K | 8.00K | 0.00 | -10.00K | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -3.07M | -7.07M | 0.00 | -70.00K | |||
| Capital Expenditure | -2.64M | -1.02M | N/A | N/A | |||
| FREE CASH FLOW | -5.71M | -8.09M | 0.00 | -70.00K | |||
All data in CAD